January 20, 2010 — Daily acyclovir therapy may not reduce the risk for HIV-1 transmission, according to the results of a randomized, placebo-controlled multicenter trial reported online in the January ...
Tenofovir decreases HSV-2 risk Oral tenofovir-based prophylaxis for HIV also reduced herpes simplex virus-2 transmission. Daily oral tenofovir-based preexposure prophylaxis (PrEP) for HIV also seemed ...
Herpes simplex virus is a master of bad timing—reappearing briefly, often unnoticed, and just long enough to keep the immune system on its toes. In its genital form, herpes simplex virus type 2 (HSV-2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results